New drug combo aims to save bladders in Muscle-Invasive cancer
NCT ID NCT07566156
First seen May 10, 2026 · Last updated May 20, 2026 · Updated 3 times
Summary
This study tests whether two drugs, enfortumab vedotin and pembrolizumab, can control muscle-invasive bladder cancer without needing surgery to remove the bladder. About 390 adults whose cancer hasn't spread outside the bladder will get either the drug combo or standard chemoradiation. The goal is to see if the combo helps patients live longer and keep their bladder cancer-free.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UROTHELIAL CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Texas Oncology
RECRUITINGAustin, Texas, 78705, United States
Conditions
Explore the condition pages connected to this study.